Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial

• Published in: International Archives of Allergy and Immunology
• Main Authors: Yorgancioglu, Arzu, Erkekol, Ferda Oner, Mungan, Dilsad, Erdinc, Munevver, Gemicioglu, Bilun, Ozseker, Zeynep Ferhan, Degirmenci, Papatya Bayrak, Nayci, Sibel, Cilli, Aykut, Erdenen, Fusun, Kirmaz, Cengiz, Ediger, Dane, Yalcin, Arzu Didem, Buyukozturk, Suna, Ozturk, Sami, Gulec, Mustafa, Isik, Sacide Rana, Kalyoncu, Ali Fuat, Goksel, Ozlem, Aydin, Omur, Havlucu, Yavuz, Ar, Idilhan Baloglu, Erdogdu, Ahmet
• Other Authors: Ege Üniversitesi
• Format: Article in Journal/Newspaper
• Language: English
• Published: Karger 2018
• Subjects: Anti-IgE; Omalizumab; Effectiveness; Real-life trial; Long-term treatment; Dane; sami
• Online Access: https://hdl.handle.net/11454/31162; https://doi.org/10.1159/000488349

WOS: 000438864700007 PubMed ID: 29772578 Background: Omalizumab has demonstrated therapeutic benefits both in controlled clinical trials and real-life studies. However, research concerning the long-term effects and tolerability of omalizumab is needed. The main objective of this study was to evaluat...